Roger Murphy

Medicine · Health Sciences

24h-index2.2kcitations42works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(16), Immunotherapy and Immune Responses(12), Receptor Mechanisms and Signaling(8), Glycosylation and Glycoproteins Research(6), HER2/EGFR in Cancer Research(5)

Publications42 total

Nuttall, D.L. (1987) 'The validity of assessments', European Journal of the Psychology of Education, II, 2, pp. 109-18.
2017
Interdependence and the FCO
2017
Conclusions
2017
Introduction
2017
Interdependence and Changes in Whitehall
2017
T cells recognizing a 11mer influenza peptide complexed to H‐2D<sup>b</sup> show promiscuity for peptide length
Immunology and Cell Biology·2015· 1 cited
Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of <sup>131</sup>I-huA33 with Concurrent Capecitabine
Journal of Nuclear Medicine·2014· 30 citedOpen Access
Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET
PLoS ONE·2012· 30 citedOpen Access
Impact on product quality of high productive GS-CHO cell lines
BMC Proceedings·2011· 1 citedOpen Access
Abstract 5318: Optimizing pharmacokinetics and targeting properties of recombinant anti-Lewis Y antibody hu3S193 in A431 tumor-bearing mice
Cancer Research·2011
Heteroclitic serological response in esophageal and prostate cancer patients after NY‐ESO‐1 protein vaccination
International Journal of Cancer·2011· 44 citedOpen Access
Optimizing pharmacokinetics and targeting properties of recombinant anti-Lewis Y antibody hu3S193 in A431 tumor bearing mice
Cancer Research·2011
Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination
International Journal of Cancer·2008· 46 citedOpen Access
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
Cancer Immunology Immunotherapy·2008· 45 citedOpen Access
Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel
Cancer Science·2008· 127 citedOpen Access
A Phase I Biodistribution and Pharmacokinetic Trial of Humanized Monoclonal Antibody Hu3s193 in Patients with Advanced Epithelial Cancers that Express the Lewis-Y Antigen
Clinical Cancer Research·2007· 73 citedOpen Access
T cell immunomonitoring and tumor responses in patients immunized with a complex of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein.
PubMed·2007· 129 citedOpen Access
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors
Proceedings of the National Academy of Sciences·2007· 217 citedOpen Access
Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients
International Journal of Cancer·2007· 75 citedOpen Access
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors (vol 104, pg 4071, 2007)
2007
page 1 of 3Next →

Frequent Co-authors

Andrew M. Scott(17), Lloyd J. Old(17), Eric W. Hoffman(14), Wendie Hopkins(9), Gerd Ritter(8), Zhanqi Liu(8), Fiona E. Smyth(8), Hiroshi Shiku(8), Duncan MacGregor(7), Achim A. Jungbluth(6), Fook-Thean Lee(6), Akiko Uenaka(6), Eiichi Nakayama(6), James P. Flinn(6), James A. Angus(6), Ian D. Davis(5), Jonathan Cebon(5), Niall C. Tebbutt(5), Carmel Murone(5), Timothy Saunder(5)